Fang Ming, Huang Wenlong, Wu Xinchi, Gao Yuan, Ou Jing, Zhang Xiaolan, Li Yanyun
Department of Endocrinology, The Affiliated Jiangyin People's Hospital, School of Medicine, Southeast University, Jiangyin, 214400, China.
Anat Rec (Hoboken). 2019 Feb;302(2):258-268. doi: 10.1002/ar.23940. Epub 2018 Nov 9.
MicroR-141-3p has been found to be downregulated in papillary thyroid carcinoma (PTC), while little is known about the cellular functions and precise signals elicited by miR-141-3p in PTC. The results of this study indicated that the expression of miR-141-3p was aberrantly down-regulated in PTC tissues and cell lines, compared with the adjacent normal tissues and normal thyroid epithelial cells. Furthermore, the miR-141-3p expression level was negatively associated with TNM stage and lymph node metastasis in PTC. Expression of miR-141-3p effectively inhibited cell growth, promoted apoptosis, and suppressed invasion in PTC cells. Meanwhile, miR-141-3p knockdown with miR-141-3p inhibitor reversed these effects. Consistent with the in vitro study, miR-141-3p also exhibited anti-neoplastic activity in vivo. Moreover, the results revealed that miR-141-3p directly recognized the 3' untranslated region (3'UTR) of Yin Yang 1 (YY1) and negatively regulated the expression of YY1 at both protein and mRNA levels. Ectopic expression of YY1 could effectively abrogate the anti-metastatic and proapoptotic effects of miR-141-3p. In summary, the findings suggested that miR-141-3p can act as a tumor suppressor in PTC and may be a potential therapeutic target for PTC treatment. Anat Rec, 302:258-268, 2019. © 2018 Wiley Periodicals, Inc.
微小RNA-141-3p(MicroR-141-3p)已被发现在甲状腺乳头状癌(PTC)中表达下调,而关于miR-141-3p在PTC中引发的细胞功能和精确信号通路却知之甚少。本研究结果表明,与相邻正常组织和正常甲状腺上皮细胞相比,miR-141-3p在PTC组织和细胞系中的表达异常下调。此外,miR-141-3p的表达水平与PTC的TNM分期和淋巴结转移呈负相关。miR-141-3p的表达有效抑制了PTC细胞的生长,促进了细胞凋亡,并抑制了细胞侵袭。同时,用miR-141-3p抑制剂敲低miR-141-3p可逆转这些作用。与体外研究一致,miR-141-3p在体内也表现出抗肿瘤活性。此外,结果显示miR-141-3p直接识别阴阳1(YY1)的3'非翻译区(3'UTR),并在蛋白质和mRNA水平上负调控YY1的表达。YY1的异位表达可有效消除miR-141-3p的抗转移和促凋亡作用。总之,这些发现表明miR-141-3p在PTC中可作为肿瘤抑制因子,可能是PTC治疗的潜在靶点。《解剖学记录》,302:258 - 268,2019年。© 2018威利期刊公司